Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure

Vaccine

Volumn 31, Issue 16, 2013, Pages 2042-2049

  Sanz Ramos, Marta ^a   Manno, Daniela ^a   Kapambwe, Mirriam ^b   Ndumba, Ida ^b   Musonda, Kunda G ^a,b   Bates, Matthew ^a   Chibumbya, Julia ^b   Siame, Joshua ^b   Monze, Mwaka ^b   Filteau, Suzanne ^a   Gompels, Ursula A ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY TEACHING HOSPITAL   (Zambia)

Author keywords

Breast feeding; Childhood HIV; Human cytomegalovirus; Maternal HIV exposure; Micronutrient; Polio vaccine

Indexed keywords

NEUTRALIZING ANTIBODY; NEVIRAPINE; POLIOMYELITIS VACCINE;

ANTIBODY TITER; ARTICLE; BREAST FEEDING; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIET; EDUCATION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; INFANT DISEASE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PERINATAL CARE; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIOECONOMICS; VERTICAL TRANSMISSION; VIREMIA;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BREAST FEEDING; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINES; VACCINATION;

EID: 84875496632     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.02.044     Document Type: Article

References (36)

1. Granich R., Crowley S., Vitoria M., Lo Y.R., Souteyrand Y., Dye C., et al. Highly active antiretroviral treatment for the prevention of HIV transmission. J Int AIDS Soc 2010, 13:1.
2. Setse R.W., Cutts F., Monze M., Ryon J.J., Quinn T.C., Griffin D.E., et al. HIV-1 infection as a risk factor for incomplete childhood immunization in Zambia. J Trop Pediatr 2006, 52(October (5)):324-328.
3. Bekker V., Scherpbier H., Pajkrt D., Jurriaans S., Zaaijer H., Kuijpers T.W. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Pediatrics 2006, 118(August (2)):e315-e322.
4. Pancharoen C., Ananworanich J., Thisyakorn U. Immunization for persons infected with human immunodeficiency virus. Curr HIV Res 2004, 2(October (4)):293-299.
5. Tejiokem M.C., Gouandjika I., Beniguel L., Zanga M.C., Tene G., Gody J.C., et al. HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the expanded program on immunization. PLoS ONE 2007, 2(12):e1260.
6. Abzug M.J., Warshaw M., Rosenblatt H.M., Levin M.J., Nachman S.A., Pelton S.I., et al. Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis 2009, 200(September (6)):935-946.
7. Tejiokem M.C., Njamkepo E., Gouandjika I., Rousset D., Beniguel L., Bilong C., et al. Whole-cell pertussis vaccine induces low antibody levels in human immunodeficiency virus-infected children living in sub-Saharan Africa. Clin Vaccine Immunol 2009, 16(April (4)):479-483.
8. Bates M., Monze M., Bima H., Kapambwe M., Kasolo F.C., Gompels U.A. High human cytomegalovirus loads and diverse linked variable genotypes in both HIV-1 infected and exposed, but uninfected, children in Africa. Virology 2008, 382(December (1)):28-36.
9. Kovacs A., Schluchter M., Easley K., Demmler G., Shearer W., La Russa P., et al. Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric pulmonary and cardiovascular complications of vertically transmitted HIV infection study group. N Engl J Med 1999, 341(July (2)):77-84.
10. Pawelec G., Derhovanessian E., Larbi A., Strindhall J., Wikby A. Cytomegalovirus and human immunosenescence. Rev Med Virol 2009, 19(January (1)):47-56.
11. Ben-Smith A., Gorak-Stolinska P., Floyd S., Weir R.E., Lalor M.K., Mvula H., et al. Differences between naive and memory T cell phenotype in Malawian and UK adolescents: a role for cytomegalovirus?. BMC Infect Dis 2008, 8:139.
12. Miles D.J., van der Sande M., Jeffries D., Kaye S., Ismaili J., Ojuola O., et al. Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J Virol 2007, 81(June (11)):5766-5776.
13. Pass R.F., Stagno S., Britt W.J., Alford C.A. Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. J Infect Dis 1983, 148(December (6)):953-961.
14. Bunders M., Thorne C., Newell M.L. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. AIDS 2005, 19(July (10)):1071-1079.
15. Clerici M., Saresella M., Colombo F., Fossati S., Sala N., Bricalli D., et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000, 96(December (12)):3866-3871.
16. Miyamoto M., Pessoa S.D., Ono E., Machado D.M., Salomao R., Succi R.C., et al. Low CD4+ T-cell levels and B-cell apoptosis in vertically HIV-exposed noninfected children and adolescents. J Trop Pediatr 2010, 56(December (6)):427-432.
17. Abramczuk B.M., Mazzola T.N., Moreno Y.M., Zorzeto T.Q., Quintilio W., Wolf P.S., et al. Impaired humoral response to vaccines among HIV-exposed uninfected infants. Clin Vaccine Immunol 2011, 18(September (9)):1406-1409.
18. Jones C.E., Naidoo S., De Beer C., Esser M., Kampmann B., Hesseling A.C. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 2011, 305(February (6)):576-584.
19. 2010 [cited; Available from: http://apps.who.int/immunization_monitoring/en/globalsummary/countryprofileselect.cfm.
20. Minor P.D. The polio-eradication programme and issues of the end game. J Gen Virol 2012, 93(March (Pt 3)):457-474.
21. Okayasu H., Sutter R.W., Czerkinsky C., Ogra P.L. Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission. Vaccine 2011, 29(October (46)):8205-8214.
22. Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Wkly Epdemiol Rec;85:213-28.
23. Ryder R.W., Oxtoby M.J., Mvula M., Batter V., Baende E., Nsa W., et al. Safety and immunogenicity of bacille Calmette-Guerin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. J Pediatr 1993, 122(May (5 Pt 1)):697-702.
24. Stringer E.M., Chintu N.T., Levy J.W., Sinkala M., Chi B.H., Muyanga J., et al. Declining HIV prevalence among young pregnant women in Lusaka, Zambia. Bull World Health Organ 2008, 86(September (9)):697-702.
25. Stringer E.M., Ekouevi D.K., Coetzee D., Tih P.M., Creek T.L., Stinson K., et al. Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries. JAMA 2010, 304(July (3)):293-302.
26. Team C.S. Micronutrient fortification to improve growth and health of maternally HIV-unexposed and exposed Zambian infants: a randomised controlled trial. PLoS ONE 2010, 5(6):e11165.
27. Herremans M.M., Reimerink J.H., Ras A., Van Der Avoort H.G., Kimman T.G., Van Loon A.M., et al. Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test. Clin Diagn Lab Immunol 1997, 4(November (6)):659-664.
28. Chi B.H., Sinkala M., Mbewe F., Cantrell R.A., Kruse G., Chintu N., et al. Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial. Lancet 2007, 370(November (9600)):1698-1705.
29. Gompels U.A., Larke N., Sanz-Ramos M., Bates M., Musonda K., Manno D., et al. Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia. Clin Infect Dis 2012, 54(February (3)):434-442.
30. Chisenga M., Siame J., Baisley K., Kasonka L., Filteau S. Determinants of infant feeding choices by Zamian mothers: a mixed quantitative and qualitative study. Mater Child Nutr 2010, 7(2):148-159.
31. Gibson R.S., Kafwembe E., Mwanza S., Gosset L., Bailey K.B., Mullen A., et al. A micronutrient-fortified food enhances iron and selenium status of Zambian infants but has limited efficacy on zinc. J Nutr 2011, 141(May (5)):935-943.
32. Hahn-Zoric M., Fulconis F., Minoli I., Moro G., Carlsson B., Bottiger M., et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatr Scand 1990, 79(December (12)):1137-1142.
33. Pabst H.F., Spady D.W. Effect of breast-feeding on antibody response to conjugate vaccine. Lancet 1990, 336(August (8710)):269-270.
34. Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine. J Infect Dis 1995 May;171(5):1097-106.
35. Palmer A.C. Nutritionally mediated programming of the developing immune system. Adv Nutr 2011, 2(September (5)):377-395.
36. Rakoto-Andrianarivelo M., Gumede N., Jegouic S., Balanant J., Andriamamonjy S.N., Rabemanantsoa S., et al. Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J Infect Dis 2008, 197(May (10)):1427-1435.